{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:42:28Z","timestamp":1786221748912,"version":"build-2736575974"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","award":["NIHR303692"],"award-info":[{"award-number":["NIHR303692"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","award":["NIHR302884"],"award-info":[{"award-number":["NIHR302884"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","award":["NIHR304079"],"award-info":[{"award-number":["NIHR304079"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001626","name":"HSC Public Health Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001626","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010756","name":"Health and Social Care Research and Development Division","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcf.2026.07.1983","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:17:24Z","timestamp":1786162644000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nutrition and cardiometabolic health in cystic fibrosis: Emerging evidence and research gaps"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2946-956X","authenticated-orcid":false,"given":"Veronica","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Sills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Snowball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian G.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0001","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin Nutr"},{"issue":"10408","key":"10.1016\/j.jcf.2026.07.1983_bib0002","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jcf.2026.07.1983_bib0003","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/thorax-2023-220100","article-title":"A refresh of the top 10 research priorities in cystic fibrosis","volume":"78","author":"Rowbotham","year":"2023","journal-title":"Thorax"},{"issue":"176","key":"10.1016\/j.jcf.2026.07.1983_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0261-2024","article-title":"Managing an ageing cystic fibrosis population: challenges and priorities","volume":"34","author":"Frost","year":"2025","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0005","article-title":"Cardiovascular disease prevention: Risk factor modification at the heart of the matter","volume":"17","author":"Fawzy","year":"2021","journal-title":"The Lancet Region Health \u2013 West Pacif"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0007","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0008","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/nu18050755","article-title":"Prevalence of Overweight and Obesity in the Era of CFTR Modulators in Patients with Cystic Fibrosis","volume":"18","author":"Bashir","year":"2026","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0009","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcf.2021.04.016","article-title":"Cardiovascular complications in cystic fibrosis: a review of the literature","volume":"21","author":"Poore","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00174-2023","article-title":"Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study","volume":"62","author":"Frost","year":"2023","journal-title":"Eur Respir J"},{"issue":"10267","key":"10.1016\/j.jcf.2026.07.1983_bib0011","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The <em>Lancet<\/em>Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0012","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251393070","article-title":"Social risk factors in patients with cystic fibrosis: impacts on exacerbations, lung function, and BMI","volume":"19","author":"Li","year":"2025","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0013","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S2213-2600(13)70002-X","article-title":"The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study","volume":"1","author":"Taylor-Robinson","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0014","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.chest.2015.08.021","article-title":"Disparities in cystic fibrosis care and outcome: socioeconomic status and beyond","volume":"149","author":"Kerem","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0740","article-title":"Association of body mass index with clinical outcomes in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"5","author":"Nagy","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2026.07.1983_bib0016","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European cystic fibrosis bone mineralisation guidelines","volume":"10","author":"Sermet-Gaudelus","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0017","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cld.2018.12.008","article-title":"Hepatic Manifestations of Cystic Fibrosis","volume":"23","author":"Sakiani","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0018","doi-asserted-by":"crossref","DOI":"10.1177\/1479973119900612","article-title":"Hospitalization rates among patients with cystic fibrosis using pancreatic enzyme replacement therapy","volume":"17","author":"Trapnell","year":"2020","journal-title":"Chron Respir Dis"},{"issue":"7","key":"10.1016\/j.jcf.2026.07.1983_bib0019","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/healthcare10071351","article-title":"Health-related quality of life in adults with cystic fibrosis: familial, occupational, social, and mental health predictors","volume":"10","author":"Ancel","year":"2022","journal-title":"Healthcare"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1983_bib0021","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jama.2017.0947","article-title":"Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States","volume":"317","author":"Micha","year":"2017","journal-title":"JAMA, J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/1747-0080.12860","article-title":"Diet quality and cardiovascular outcomes: A systematic review and meta-analysis of cohort studies","volume":"81","author":"Taylor","year":"2024","journal-title":"Nutr Diet"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0023","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/advances\/nmab086","article-title":"Effects of Dietary patterns on biomarkers of inflammation and immune responses: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Koelman","year":"2022","journal-title":"Adv Nutr"},{"issue":"28","key":"10.1016\/j.jcf.2026.07.1983_bib0024","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/eurheartj\/ehad211","article-title":"Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials","volume":"44","author":"Koch","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/nu11020338","article-title":"DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses","volume":"11","author":"Chiavaroli","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101869","article-title":"Dietary patterns and biomarkers of oxidative stress and inflammation: a systematic review of observational and intervention studies","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Redox Biol"},{"issue":"12","key":"10.1016\/j.jcf.2026.07.1983_bib0027","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jand.2020.08.076","article-title":"Diet quality as assessed by the healthy eating index, alternate healthy eating index, dietary approaches to stop hypertension score, and health outcomes: a second update of a systematic review and meta-analysis of cohort studies","volume":"120","author":"Morze","year":"2020","journal-title":"J Acad Nutr Diet"},{"issue":"23","key":"10.1016\/j.jcf.2026.07.1983_bib0028","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1161\/CIR.0000000000001031","article-title":"2021 dietary guidance to improve cardiovascular health: a scientific statement from the american heart association","volume":"144","author":"Lichtenstein","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0029","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/1747-0080.12882","article-title":"Dietary intake and quality among adults with cystic fibrosis: a systematic review","volume":"81","author":"Thornton","year":"2024","journal-title":"Nutr Diet"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcf.2023.08.004","article-title":"What do people with cystic fibrosis eat? Diet quality, macronutrient and micronutrient intakes (compared to recommended guidelines) in adults with cystic fibrosis\u2013a systematic review","volume":"22","author":"Greaney","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2026.07.1983_bib0031","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jand.2020.03.016","article-title":"Dietary macronutrient distribution and nutrition outcomes in persons with cystic fibrosis: an evidence analysis center systematic review","volume":"121","author":"McDonald","year":"2021","journal-title":"J Acad Nutr Diet"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0032","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jcf.2026.03.026","article-title":"Changes in nutritional priorities and management in people with CF","volume":"25","author":"Alvarez","year":"2026","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0034","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41366-024-01710-4","article-title":"Association between early age body mass index and the risk of adulthood cardiovascular diseases: a systematic review and meta-analysis","volume":"49","author":"Qiu","year":"2025","journal-title":"Int J Obes"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1983_bib0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0036","unstructured":"National child measurement programme (NCMP) annual report, academic year 2024 to 2025, England [Available from: https:\/\/www.gov.uk\/government\/statistics\/national-child-measurement-programme-ncmp-annual-report-academic-year-2024-to-2025-england."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0037","unstructured":"UK Cystic Fibrosis Registry 2024 Annual Data Report (2025), Cystic Fibrosis Trust. London [cited 2026 Feb 24]. Available from: https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2025-10\/CFT_2024_Annual_Data_Report_v7.pdf."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0038","unstructured":"Australian, CF data registry 2024 annual report [cited 2026 Feb 24]. Available from: https:\/\/www.cysticfibrosis.org.au\/cf-data-registry\/."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0039","unstructured":"Canadian. C.F Registry annual report 2023 [cited 2026 Feb 24]. Available from: https:\/\/cystic-fibrosis.cdn.prismic.io\/cystic-fibrosis\/Z9sI9jiBA97GirFZ_2023-Annual-Data-ReportWEB-2-.pdf."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0040","series-title":"Cystic Fibrosis Foundation Patient Registry Highlights","year":"2024"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112091","article-title":"Dietary intake, weight status, pulmonary function, and metabolic profile in children with cystic fibrosis with or without pancreatic sufficiency","volume":"114","author":"Papachristou","year":"2023","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0042","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ppul.26797","article-title":"Body composition in children with cystic fibrosis treated with CFTR modulators versus modulator na\u00efve individuals","volume":"59","author":"Dress","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0043","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clnu.2025.04.027","article-title":"Dietary intake remains unchanged while nutritional status improves in children and adults with cystic fibrosis on Elexacaftor\/Tezacaftor\/Ivacaftor","volume":"50","author":"Enaud","year":"2025","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0044","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jcf.2024.01.011","article-title":"Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries","volume":"23","author":"Calthorpe","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0045","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jcf.2023.03.011","article-title":"A paradigm shift in cystic fibrosis nutritional care: Clinicians' views on the management of patients with overweight and obesity","volume":"22","author":"Snowball","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0046","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcf.2023.06.010","article-title":"Body mass index and nutritional intake following Elexacaftor\/Tezacaftor\/Ivacaftor modulator therapy in adults with cystic fibrosis","volume":"22","author":"Caley","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"19","key":"10.1016\/j.jcf.2026.07.1983_bib0048","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.3390\/nu16193293","article-title":"Impact of elexacaftor\u2013tezacaftor\u2013ivacaftor therapy on body composition, dietary intake, biomarkers, and quality of life in people with cystic fibrosis: a prospective observational study","volume":"16","author":"Hevilla","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0049","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy balance and mechanisms of weight gain with ivacaftor treatment of cystic fibrosis gating mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1983_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70067","article-title":"The effects of acute aerobic exercise on appetite-regulating parameters and energy intake in males with obesity","volume":"7","author":"Khodabandeh","year":"2024","journal-title":"Health Sci Rep"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0051","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3945\/ajcn.112.051409","article-title":"Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study123","volume":"97","author":"Stephenson","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0052","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74502-1","article-title":"Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry","volume":"10","author":"Earnest","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0053","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0740","article-title":"Association of body mass index with clinical outcomes in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"5","author":"Nagy","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.910","article-title":"The relationship between weight and pulmonary outcomes in overweight and obese people with cystic fibrosis: a retrospective observational study","volume":"5","author":"Welter","year":"2022","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fped.2014.00033","article-title":"Body composition and pulmonary function in cystic fibrosis","volume":"2","author":"Sheikh","year":"2014","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0056","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/nu14020310","article-title":"The relationship between body composition, dietary intake, physical activity, and pulmonary status in adolescents and adults with cystic fibrosis","volume":"14","author":"Scully","year":"2022","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0057","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ajcnut.2025.09.019","article-title":"Relationship between skeletal muscle indicators and clinical outcomes in cystic fibrosis is modified by adiposity and CFTR modulator use: a cross-sectional analysis","volume":"122","author":"Gonzalez Ramirez","year":"2025","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0058","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nut.2015.10.012","article-title":"Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity","volume":"32","author":"Alvarez","year":"2016","journal-title":"Nutrition"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1983_bib0059","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.clnu.2019.12.029","article-title":"Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors","volume":"39","author":"Bonhoure","year":"2020","journal-title":"Clin Nutr"},{"issue":"S1","key":"10.1016\/j.jcf.2026.07.1983_bib0060","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1002\/ppul.26806","article-title":"Nutritional status in the era of highly effective CFTR modulators","volume":"59","author":"Bass","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0061","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/nu14061216","article-title":"The changing landscape of nutrition in cystic fibrosis: the emergence of overweight and obesity","volume":"14","author":"Bailey","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0062","first-page":"367","article-title":"Beyond BMI: nutritional recovery and functional implications of cftr modulators in cystic fibrosis","volume":"15","author":"Linguiti","year":"2026","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0063","article-title":"Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass","volume":"14 - 2023","author":"Mouzaki","year":"2023","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0064","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jcf.2019.01.002","article-title":"Visceral adipose tissue is associated with poor diet quality and higher fasting glucose in adults with cystic fibrosis","volume":"18","author":"Bellissimo","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0065","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12523","article-title":"Cardiometabolic risk factors in adults with normal weight obesity: a systematic review and meta-analysis","volume":"12","author":"Rakhmat","year":"2022","journal-title":"Clin Obes"},{"issue":"7","key":"10.1016\/j.jcf.2026.07.1983_bib0066","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/CS20140553","article-title":"Normal weight individuals who develop Type 2 diabetes: the personal fat threshold","volume":"128","author":"Taylor","year":"2015","journal-title":"Clin Sci"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0067","series-title":"Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand","author":"Saxby","year":"2017"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0068","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-8587(23)00058-X","article-title":"<em>Lancet diabetes & endocrinology<\/em>commission on the definition and diagnosis of clinical obesity","volume":"11","author":"Rubino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0069","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.jcf.2026.07.1983_bib0070","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"J Acad Nutr Diet"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0071","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jcf.2023.05.010","article-title":"Nutritional considerations for a new era: a CF foundation position paper","volume":"22","author":"Leonard","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0072","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s13679-020-00398-7","article-title":"Socioeconomics of Obesity","volume":"9","author":"Anekwe","year":"2020","journal-title":"Curr Obes Rep"},{"issue":"10","key":"10.1016\/j.jcf.2026.07.1983_bib0073","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/metabo12100954","article-title":"Metabolic Disorders in Menopause","volume":"12","author":"Jeong","year":"2022","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0074","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/10901981231178697","article-title":"Weight Bias: A Narrative Review of the Evidence, Assumptions, Assessment, and Recommendations for Weight Bias in Health Care","volume":"50","author":"Peterson","year":"2023","journal-title":"Health Educ Behav"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0075","doi-asserted-by":"crossref","DOI":"10.1111\/dme.70190","article-title":"Relationship between patient activation, experienced stigma, and internalised weight stigma in people with type 2 diabetes","volume":"43","author":"Sims","year":"2026","journal-title":"Diabetic Med"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0076","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15440","article-title":"Associations between weight self-stigma and healthy diet and physical activity among adults with type 2 diabetes: Cross-sectional results from the second Diabetes MILES \u2013 Australia (MILES-2) study","volume":"42","author":"Manallack","year":"2025","journal-title":"Diabetic Med"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108387","article-title":"Weight stigma and diabetes stigma in U.S. adults with type 2 diabetes: associations with diabetes self-care behaviors and perceptions of health care","volume":"168","author":"Puhl","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0078","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcf.2024.11.009","article-title":"Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"24","author":"Gramegna","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0079","doi-asserted-by":"crossref","first-page":"A3919","DOI":"10.1016\/j.chest.2023.07.2557","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor is associated with Increased Prevalence of Hypertenion in Cystic Fibrosis","volume":"164","author":"Ross","year":"2023","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1983_bib0080","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/oby.23505","article-title":"Impact of program characteristics on weight loss in adult behavioral weight management interventions: systematic review and component network meta-analysis","volume":"30","author":"Hartmann-Boyce","year":"2022","journal-title":"Obesity"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0081","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","article-title":"European guidelines for obesity management in adults","volume":"8","author":"Yumuk","year":"2015","journal-title":"Obes Facts"},{"issue":"12","key":"10.1016\/j.jcf.2026.07.1983_bib0082","article-title":"A comprehensive review of the role of glp-1 agonists in weight management and their effect on metabolic parameters such as blood glucose, cholesterol, and blood pressure","volume":"16","author":"Gul","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.jcf.2026.07.1983_bib0083","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1097\/MS9.0000000000001472","article-title":"Recent advances in bariatric surgery: a narrative review of weight loss procedures","volume":"85","author":"Aderinto","year":"2023","journal-title":"Ann Med Surg"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0084","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcf.2024.08.005","article-title":"Glucagon-like-peptide-1 agonist therapy in adults with cystic fibrosis","volume":"24","author":"Park","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcf.2025.10.006","article-title":"Impact of glucagon-like-peptide-1 receptor agonist therapy on pulmonary function in people with cystic fibrosis who achieve normal body mass index","volume":"25","author":"Horvit","year":"2026","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0086","unstructured":"National Institute of Health and Care Research. Awards and outputs [cited 2026 Feb 17th]. Available from: https:\/\/www.fundingawards.nihr.ac.uk\/award\/NIHR302884."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0087","unstructured":"Cystic Fibrosis Trust, Clinical Trials, Trialtracker [cited 2026 Feb 17th]. Available from: https:\/\/www.cysticfibrosis.org.uk\/get-involved\/clinical-trials\/trialstracker\/tt014826."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0088","doi-asserted-by":"crossref","DOI":"10.1177\/1179551419851770","article-title":"Cystic fibrosis-related diabetes: pathophysiology and therapeutic challenges","volume":"12","author":"Kelsey","year":"2019","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0089","first-page":"23","article-title":"Cystic fibrosis related diabetes (CFRD) in the era of modulators: a scoping review","volume":"46","author":"Prentice","year":"2023","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107664","article-title":"Cohen-Cymberknoh M. Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis","volume":"228","author":"Cohen","year":"2024","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0091","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcf.2026.04.004","article-title":"Association of CFRD development among females with CF who use hormonal contraception","volume":"25","author":"Khan","year":"2026","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0092","unstructured":"Shaw J. Strategic research centre: diabetes [Available from: https:\/\/www.cysticfibrosis.org.uk\/research\/cf-research-topics\/understanding-and-treating-symptoms\/src-7-shaw-diabetes."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0093","unstructured":"Kaput K.L, Neece A.R, Stewart K.L, Stoddard G.J, Wang V.H, Liou T.G. Evaluation of family history of diabetes and the development of cystic fibrosis-related diabetes in a clinical cystic fibrosis cohort. Endocrine Practice."},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0094","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis\u2013related diabetes","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0095","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820966428","article-title":"Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes","volume":"11","author":"Kempegowda","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0096","article-title":"Coronary artery disease in patients with cystic fibrosis - a case series and review of the literature","volume":"30","author":"Sandouk","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"issue":"12","key":"10.1016\/j.jcf.2026.07.1983_bib0097","doi-asserted-by":"crossref","first-page":"436","DOI":"10.31083\/j.rcm2512436","article-title":"Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies","volume":"25","author":"Siam","year":"2024","journal-title":"Rev Cardiovasc Med"},{"issue":"2_suppl","key":"10.1016\/j.jcf.2026.07.1983_bib0098","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications","volume":"26","author":"Dal Canto","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0099","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00125-025-06653-7","article-title":"The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review","volume":"69","author":"Sharpe","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0100","article-title":"Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study","volume":"11 - 2024","author":"Scully","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0101","unstructured":"The effects of a low glycemic load diet on dysglycemia and body composition in adults with cystic fibrosis-related diabetes (DINE) [Available from: https:\/\/clinicaltrials.gov\/study\/NCT05723445#study-plan]."},{"issue":"8","key":"10.1016\/j.jcf.2026.07.1983_bib0102","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.clnu.2019.11.004","article-title":"Dietary intake in cystic fibrosis and its role in glucose metabolism","volume":"39","author":"Armaghanian","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0103","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcf.2019.08.003","article-title":"Cystic fibrosis related diabetes: medical management","volume":"18","author":"Ode","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0104","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.tjnut.2025.03.021","article-title":"Umbrella review of systematic reviews and meta-analyses on consumption of different food groups and risk of type 2 diabetes mellitus and metabolic syndrome","volume":"155","author":"Banjarnahor","year":"2025","journal-title":"J Nutr"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0105","series-title":"Dietary Patterns and Risk of Type 2 Diabetes: A Systematic Review [Internet]","author":"Talegawkar","year":"2024"},{"issue":"12","key":"10.1016\/j.jcf.2026.07.1983_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2025.100562","article-title":"Adherence to mediterranean diet and risk of type 2 diabetes: an updated systematic review and dose\u2013response meta-analysis","volume":"16","author":"Wallerer","year":"2025","journal-title":"Adv Nutr"},{"issue":"24","key":"10.1016\/j.jcf.2026.07.1983_bib0107","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.3390\/nu17243908","article-title":"Impact of the mediterranean diet on glycemic control, body mass index, lipid profile, and blood pressure in type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"17","author":"Wu","year":"2025","journal-title":"Nutrients"},{"issue":"14","key":"10.1016\/j.jcf.2026.07.1983_bib0108","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/nu15143156","article-title":"Effect of dietary approaches on glycemic control in patients with type 2 diabetes: a systematic review with network meta-analysis of randomized trials","volume":"15","author":"Jing","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0109","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S2213-8587(24)00069-X","article-title":"Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127\u2009594 people from 20 countries (PURE): a prospective cohort study","volume":"12","author":"Miller","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0110","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4093\/dmj.2024.0706","article-title":"Ultra-processed food intake and risk of type 2 diabetes mellitus: a dose-response meta-analysis of prospective studies","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab J"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0111","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000664","article-title":"Diet in the management of type 2 diabetes: umbrella review of systematic reviews with meta-analyses of randomised controlled trials","volume":"2","author":"Szczerba","year":"2023","journal-title":"BMJ Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0112","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0113","doi-asserted-by":"crossref","first-page":"e1444","DOI":"10.1210\/clinem\/dgab857","article-title":"Continuous glucose monitoring and hba1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis","volume":"107","author":"Scully","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0114","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcf.2021.07.016","article-title":"Continuous glucose monitoring in cystic fibrosis\u2013benefits, limitations, and opportunities","volume":"20","author":"Chan","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0115","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jcf.2019.08.025","article-title":"Continuous glucose monitoring in cystic fibrosis \u2013 a practical guide","volume":"18","author":"Chan","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0116","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/medicina60030477","article-title":"The role of continuous glucose monitoring in detecting early dysglycemia and clinical outcomes in patients with cystic fibrosis","volume":"60","author":"Kirigin Bilo\u0161","year":"2024","journal-title":"Medicina (B Aires)"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0117","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2337\/dc25-2936","article-title":"Relationship between laboratory-measured hba1c and continuous glucose monitoring\u2013derived glucose management indicator in adults with cystic fibrosis\u2013related diabetes","volume":"49","author":"Kadiyala","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0118","first-page":"229","article-title":"Continuous glucose monitoring as an alternative for Cystic Fibrosis Related diabetes screening and diagnosis","author":"Aguilera Garc\u00eda","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0119","unstructured":"Apsan J., Gandhi K., Perdomo Rodriguez J.P, Bianco M.E, Bartz S.K, Chan C.L. Cystic fibrosis\u2013related diabetes: pathophysiology, spectrum of glycemic abnormalities, and evolving approaches to screening. Endocrine Pract."},{"issue":"8","key":"10.1016\/j.jcf.2026.07.1983_bib0120","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcjd.2021.03.005","article-title":"Glycated hemoglobin as a first-line screening test for cystic fibrosis\u2012related diabetes and impaired glucose tolerance in children with cystic fibrosis: a validation study","volume":"45","author":"Racine","year":"2021","journal-title":"Can J Diabetes"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0121","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcjd.2024.09.001","article-title":"Cystic Fibrosis\u2013related Diabetes: a first canadian clinical practice guideline","volume":"49","author":"Canadian","year":"2025","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0122","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","article-title":"Cystic fibrosis related diabetes: pathophysiology, screening and diagnosis","volume":"18","author":"Granados","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.eprac.2026.04.007","article-title":"Agreement between hba1c and continuous glucose monitoring\u2013derived glycemic metrics in adults with cystic fibrosis related diabetes","author":"Ahmed","year":"2026","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0124","article-title":"Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: A French survey from the 47 centers","volume":"28","author":"Weiss","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0125","article-title":"A provider survey of cystic fibrosis related diabetes screening and management practices at North American CF centers","volume":"14 - 2023","author":"Hicks","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10.1016\/j.jcf.2026.07.1983_bib0126","article-title":"Drug treatments for managing cystic fibrosis-related diabetes","author":"Onady","year":"2020","journal-title":"Cochrane Database System Rev"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0127","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/dia.2021.0354","article-title":"The effect of control iq hybrid closed loop technology on glycemic control in adolescents and adults with cystic fibrosis-related diabetes","volume":"24","author":"Scully","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1983_bib0128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/dia.2025.0075","article-title":"The effect of omnipod 5 automated insulin delivery on glycemic control in adolescents and adults with cystic fibrosis-related diabetes","volume":"27","author":"Scully","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/dc23-1411","article-title":"Randomized trial of the insulin-only ilet bionic pancreas for the treatment of cystic fibrosis\u2013 related diabetes","volume":"47","author":"Sherwood","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0130","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.eprac.2026.03.097","article-title":"Automated insulin delivery systems in cystic fibrosis-related diabetes: a systematic review and meta-analysis","volume":"32","author":"Souza","year":"2026","journal-title":"Endocrine Practice"},{"issue":"10","key":"10.1016\/j.jcf.2026.07.1983_bib0131","doi-asserted-by":"crossref","first-page":"V","DOI":"10.1136\/bmjopen-2025-111408","volume":"15","author":"Kadiyala","year":"2025","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0132","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00125-022-05857-5","article-title":"Cardiovascular outcomes in type 1 and type 2 diabetes","volume":"66","author":"Rosengren","year":"2023","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.jcf.2026.07.1983_bib0133","article-title":"Cardiovascular system involvement in cystic fibrosis","volume":"13","author":"Shah","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0134","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1513\/AnnalsATS.201909-671CME","article-title":"The extrapulmonary effects of cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis","volume":"17","author":"Sergeev","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0135","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0136","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.18148","article-title":"Cardiovascular risk factors in childhood and adulthood and cardiovascular disease in middle age","volume":"7","author":"Kartiosuo","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0137","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00408-017-0029-y","article-title":"Increased soluble VCAM-1 and normal p-selectin in cystic fibrosis: a cross-sectional study","volume":"195","author":"Nowak","year":"2017","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0138","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4103\/2230-8210.98016","article-title":"Dyslipidemia in racially admixtured children with cystic fibrosis","volume":"16","author":"Alves","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0139","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ypmed.2012.02.006","article-title":"Improvement of the lipid profile with exercise in obese children: A systematic review","volume":"54","author":"Escalante","year":"2012","journal-title":"Prev Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0140","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jcf.2023.07.001","article-title":"Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy","volume":"22","author":"Yuzyuk","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0141","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/nu13061801","article-title":"Change in nutrient and dietary intake in european children with cystic fibrosis after a 6-month intervention with a self-management mhealth tool","volume":"13","author":"Calvo-Lerma","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0142","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jhn.12703","article-title":"The lived experience of adults with cystic fibrosis: what they would tell their younger selves about the gut","volume":"33","author":"Cave","year":"2020","journal-title":"J Hum Nutr Dietetics"},{"issue":"10","key":"10.1016\/j.jcf.2026.07.1983_bib0143","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007020.pub4","article-title":"Antioxidant supplementation for lung disease in cystic fibrosis","volume":"2019","author":"Ciofu","year":"2019","journal-title":"Cochrane Database System Rev"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0144","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1590\/1516-3180.2016.008607072016","article-title":"The role of dietary fatty acid intake in inflammatory gene expression: a critical review","volume":"135","author":"Rocha","year":"2017","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100997","article-title":"Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis","volume":"38","author":"Khan","year":"2021","journal-title":"EClinicalMed"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0146","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3390\/nu14040853","article-title":"Nutrition in Cystic Fibrosis\u2014Some Notes on the Fat Recommendations","volume":"14","author":"Strandvik","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0147","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcf.2025.10.011","article-title":"Persistent plasma and RBC fatty acid abnormalities in children and adolescents with cystic fibrosis on highly effective CFTR modulators","volume":"25","author":"Yuzyuk","year":"2026","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0148","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/nu15041036","article-title":"Nutritional approaches to modulate cardiovascular disease risk in systemic lupus erythematosus: a literature review","volume":"15","author":"Pesqueda-Cendejas","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0149","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12937-021-00663-y","article-title":"Diet intervention improves cardiovascular profile in patients with rheumatoid arthritis: results from the randomized controlled cross-over trial ADIRA","volume":"20","author":"Hulander","year":"2021","journal-title":"Nutr J"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1983_bib0150","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.3390\/nu13093208","article-title":"The effect of dietary interventions on chronic inflammatory diseases in relation to the microbiome: a systematic review","volume":"13","author":"Wagenaar","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0151","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmic.2023.100096","article-title":"Implications of the gut microbiome in cardiovascular diseases: Association of gut microbiome with cardiovascular diseases, therapeutic interventions and multi-omics approach for precision medicine","volume":"19","author":"Singh","year":"2024","journal-title":"Med Microecol"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0152","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0153","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03420-24","article-title":"Persistent delay in maturation of the developing gut microbiota in infants with cystic fibrosis","volume":"16","author":"Verster","year":"2025","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0154","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/adc.76.1.35","article-title":"Connett GJ. Dietary fibre and the occurrence of gut symptoms in cystic fibrosis","volume":"76","author":"Gavin","year":"1997","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0155","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcf.2020.04.007","article-title":"Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment","volume":"19","author":"Kristensen","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0156","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s10620-022-07812-1","article-title":"Cystic fibrosis-related gut dysbiosis: a systematic review","volume":"68","author":"Caley","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0157","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/codi.16472","article-title":"A systematic review of the colorectal microbiome in adult cystic fibrosis patients","volume":"25","author":"Gilbert","year":"2023","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0158","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01935-23","article-title":"Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor","volume":"15","author":"Reasoner","year":"2024","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0159","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jcf.2024.05.002","article-title":"Impact of extended Elexacaftor\/Tezacaftor\/Ivacaftor therapy on the gut microbiome in cystic fibrosis","volume":"23","author":"Marsh","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0160","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2359677","article-title":"The human gut microbiome and aging","volume":"16","author":"Bradley","year":"2024","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0161","first-page":"133","article-title":"Environmental Factors Affecting the Gut Microbiota and Their Consequences","volume":"2","author":"Karahan","year":"2024","journal-title":"Nature Cell and Science"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0162","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2350785","article-title":"Diet-microbiota associations in gastrointestinal research: a systematic review","volume":"16","author":"Duncanson","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0163","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12937-024-01060-x","article-title":"The impact of dietary patterns on gut microbiota for the primary and secondary prevention of cardiovascular disease: a systematic review","volume":"24","author":"Yu","year":"2025","journal-title":"Nutr J"},{"issue":"18","key":"10.1016\/j.jcf.2026.07.1983_bib0164","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.3390\/nu16183134","article-title":"The effect of dietary types on gut microbiota composition and development of non-communicable diseases: a narrative review","volume":"16","author":"Soldan","year":"2024","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.jcf.2026.07.1983_bib0165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1983_bib0166","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/life14050559","article-title":"Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications","volume":"14","author":"Facchin","year":"2024","journal-title":"Life"},{"issue":"10520","key":"10.1016\/j.jcf.2026.07.1983_bib0167","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/S0140-6736(25)01565-X","article-title":"Ultra-processed foods and human health: the main thesis and the evidence","volume":"406","author":"Monteiro","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0168","article-title":"Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses","volume":"384","author":"Lane","year":"2024","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1983_bib0169","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.clnu.2018.12.024","article-title":"Dietary fat, the gut microbiota, and metabolic health - A systematic review conducted within the MyNewGut project","volume":"38","author":"Wolters","year":"2019","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1983_bib0170","article-title":"Probiotics for people with cystic fibrosis","volume":"1","author":"Coffey","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0171","article-title":"Effectiveness of probiotics, prebiotics, and symbiotic supplementation in cystic fibrosis patients: a systematic review and meta-analysis of clinical trials","volume":"61","author":"Cruz Mosquera","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1983_bib0172","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcf.2021.11.014","article-title":"Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis","volume":"21","author":"Marsh","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0173","doi-asserted-by":"crossref","unstructured":"Holaman J.R, Sills D.J, Saumtally H.A, Johnson C.C, Recto A.A, Marsh R., et al. Distinct Gastrointestinal Symptom Phenotypes in Adults with Cystic Fibrosis are linked to complications and medication use. medRxiv. 2026:2026.01.16.26344251.","DOI":"10.64898\/2026.01.16.26344251"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1983_bib0174","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcf.2022.10.006","article-title":"Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis","volume":"22","author":"Group","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1983_bib0175","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jcf.2020.12.021","article-title":"Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms","volume":"20","author":"Freeman","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2026.07.1983_bib0176","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/2050640619841545","article-title":"A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders","volume":"7","author":"Hayee","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0177","unstructured":"Understanding Gut Symptoms in People With Cystic Fibrosis (GRAMPUS-CF SRC). Cited 2026 June 10. [Available from: ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT05934656]."},{"issue":"18","key":"10.1016\/j.jcf.2026.07.1983_bib0178","article-title":"A grumbling concern: a survey of gastrointestinal symptoms in cystic fibrosis in the modulator era [version 2; peer review: 2 approved, 3 approved with reservations]","volume":"3","author":"Calthorpe","year":"2024","journal-title":"NIHR Open Res"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0179","unstructured":"Pancreatic, nutritional and clinical outcomes in children 0-5 years with cystic fibrosis during the first 2 years of CFTR modulator therapy (PaNC): a multicentre prospective observational study. Cited 2026. June 10. [Available from: Registry ANZCT. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=387509&isReview=true]."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0180","unstructured":"Impact of elexacaftor-tezacaftor-ivacaftor treatment on metabolic, epigenetic and fecal microbiota profiles in people with cystic fibrosis. Cited 2026 June 10th. [Available from: ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT07363304]."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0181","unstructured":"Role of body fat distribution in metabolic and pulmonary decline in cystic fibrosis (ORBIT-CF). Cited 2026 june 10. Available from: ClinicalTrials\/NCT04002882. https:\/\/trial.medpath.com\/clinical-trial\/a805144c306441b4\/nct04002882-body-fat-distribution-metabolic-pulmonary-decline-cystic-fibrosis."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0182","unstructured":"Strength and muscle related outcomes for nutrition and lung function in CF. Cited 2026 June 10. Available from: ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT05639556."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0183","unstructured":"Hormonal responses to a mixed meal in people with cystic fibrosis. Cited 2026 Feb 17th. [Available from: https:\/\/clinicaltrials.gov\/study\/NCT06163482."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0184","unstructured":"Continuous glucose monitoring and OGTT screen for cystic fibrosis related diabetes in cystic fibrosis. Cited 2026 February 17th. [Available from: https:\/\/clinicaltrials.gov\/study\/NCT06560463."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0185","unstructured":"Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD). Cited 2026 June 10th. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT07102043."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0186","unstructured":"Effect of GLP-1 agonist therapy on insulin secretion in adults with pancreatic insufficient cystic fibrosis and abnormal glucose tolerance. Cited 2026 June 15th. [Accessed from: https:\/\/clinicaltrials.gov\/study\/NCT04731272]."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0187","unstructured":"Evaluating continuous glucose monitoring and metabolic profiles in adults with Cystic Fibrosis Related Diabetes (CFRD). Cited 2026 June 10th. [Available from: Registry ANZCT. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12624000024549]."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0188","unstructured":"Empagliflozin in cystic fibrosis related diabetes. Cited 2026 June 10th. [Available from: Registry AnZCT. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=390805&isReview=true]."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0189","unstructured":"MED-CF Study. HSC R&D Division, Northern Ireland, HSC Fellowship Awards [cited 2026 Feb 17th. Available from: https:\/\/research.hscni.net\/hsc-fellowship-awards."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0190","unstructured":"A pilot and feasibility study to evaluate high vs low glycemic index mixed meal tolerance test in adolescents and young adults with cystic fibrosis. Cited 2026 February 17th. [Available from: https:\/\/clinicaltrials.gov\/study\/NCT06350149."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0191","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-092503","article-title":"Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study","volume":"14","author":"Zaveri","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcf.2026.07.1983_bib0192","unstructured":"Gastrointestinal response of pediatric cystic fibrosis patients on mediterranean diet (MedDietCF). Cited 2026 June 10th. [Available from: ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT07223255]."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0193","unstructured":"Nutrition supplement for cystic fibrosis. Cited 2026 June 10th. Available from: Registry UCT. https:\/\/ichgcp.net\/clinical-trials-registry\/NCT07163078."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0194","unstructured":"Feeding practices in infants and young children with Cystic Fibrosis: An Australian survey of caregivers. Cited 2026 June 12th. [Available from: Registry ANZCT. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=389882&isReview=true]."},{"key":"10.1016\/j.jcf.2026.07.1983_bib0195","unstructured":"CF Trust, Research, GRAMPUS SRC [cited 2026 Feb 17th. Available from: https:\/\/www.cysticfibrosis.org.uk\/research\/our-research-goals\/treating-all-of-the-symptoms-of-cf-throughout-the-body\/GRAMPUS-SRC."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326036581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326036581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:52:38Z","timestamp":1786218758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326036581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":193,"alternative-id":["S1569199326036581"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.07.1983","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition and cardiometabolic health in cystic fibrosis: Emerging evidence and research gaps","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.07.1983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}